Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MOBKL1B Antibody (2D3D11) - BSA Free, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

$548.00

Specifications

Antigen MOBKL1B
Clone 2D3D11
Concentration 1 mg/mL
Dilution Western Blot 1:500-1:2000, Flow Cytometry 1:200-1:400, ELISA 1:10000
Applications Western Blot, Flow Cytometry, ELISA, Immunohistochemistry
View More Specs

Products 1
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
NBP2-61873
SDP
View Documents
Novus Biologicals
NBP261873
0.1 mL
Each of 1 for $548.00
Only null left
Add to Cart
 
Description

Description

MOBKL1B Monoclonal specifically detects MOBKL1B in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA.
Specifications

Specifications

MOBKL1B
1 mg/mL
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry
Unconjugated
Mouse
C2orf6, chromosome 2 open reading frame 6, FLJ10788, FLJ11595, MATS1, MOB1, Mob1 alpha, Mob1 homolog 1B, MOB1, Mps One Binder kinase activator-like 1B (yeast), mob1A, Mob4B, MOBK1B, mps one binder kinase activator-like 1B, Protein Mob4B
MOB1A
IgG2b
Protein G purified
2D3D11
Western Blot 1:500-1:2000, Flow Cytometry 1:200-1:400, ELISA 1:10000
Monoclonal
Purified
Cancer
55233
Purified recombinant fragment of human MOB1A (AA: 1-216) expressed in E. Coli.
Primary
25 kDa
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.